Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

PrEP policies and guidelines news

Show

From To
USPSTF Recommendation for PrEP: Reflections on Insurance Coverage and HIV Prevention for Older Adults

An “A” letter grade indicates that the panel recommends the service and finds there is high certainty that the service has a substantial net benefit. This recommendation will help improve access to PrEP by urging health care providers to offer PrEP to people at risk for HIV. It will also trigger statutory coverage requirements for health plans and create other opportunities for making PrEP more affordable.

Published
17 June 2019
From
O'Neill Institute
Ireland: PrEP programme to reduce HIV rates to be rolled out later this year

THE PrEP HIV prevention programme will be implemented in 2019, Health Minister Simon Harris said today. “We want to reduce the number of new HIV diagnoses in Ireland. Increasing the availability of PrEP will help us to do so. This report not only confirms that PrEP can help to prevent HIV amongst those who are high risk, it also shows how a PrEP programme could save money,” said Harris.

Published
17 June 2019
From
Journal.ie
US insurers must now cover PrEP

An influential guidelines body in the United States has put its full weight behind pre-exposure prophylaxis (PrEP) to people at high risk of HIV. The grade A recommendation

Published
11 June 2019
By
Roger Pebody
This drug could end HIV. Why hasn't it? (Podcast)

Dr. Robert Grant developed a treatment — a daily pill known as pre-exposure prophylaxis, or PrEP — that could stop the AIDS crisis. We look at why that hasn’t happened.

Published
06 June 2019
From
New York Times
HIV prevention pill to get insurance benefit in Korea

The government has decided to allow reimbursement for Gilead’s Truvada (tenofovir disoproxil fumarate/emtricitabine) for pre-exposure prophylaxis (PrEP). The Ministry of Health and Welfare on Tuesday said it would grant insurance benefit for Truvada HIV-1 PrEP used for people who are negative in HIV-1 infection but at high risk due to sex with an HIV-positive partner, starting from June 7.

Published
02 June 2019
From
Korea Biomedical Review
California may make anti-HIV drug available without prescription for 30 days

Democratic Sen. Scott Wiener has proposed a bill that would allow people to receive their first 30 days of PrEP over the counter if they first receive counseling and an HIV test. But the bill faces opposition from the California Medical Association, which represents doctors, and major insurance companies.

Published
02 June 2019
From
San Francisco Chronicle
UK's biggest sexual health clinic has just dropped its PrEP prices

PrEP has become more affordable at London’s leading sexual health clinic. The 56 Dean Street clinic opened its PrEP Shop in February last year and provides the HIV preventative medication for those eligible for NHS care. It will cost as little as £17.50 per month.

Published
02 June 2019
From
Gay Star News
Is Off-Label HIV Prevention Better Than None?

Rather than prescribe F/TDF as PrEP, Michael Saag, MD said, prescribers should sidestep the brand-name product and instead give their PrEP-eligible patients a generic HIV drug combination that uses lamivudine (3TC) with TDF.

Published
31 May 2019
From
MedPage Today (requires free registration)
The truth is you can afford the medication that prevents HIV. Here’s how.

It’s not the cost of PrEP that keeps more patients from accessing it; it’s the lack of awareness and the daunting nature of our complicated healthcare system.

Published
24 May 2019
From
LGBTQ Nation
A Review of the Congressional Hearing on HIV Drug Pricing

In an effort to best encapsulate the remarks of many of the members of the House and the powerful testimony of the HIV advocates present at the recent Congressional hearing on drug pricing around Gilead Sciences’ HIV prevention drug Truvada, we thought it was best to provide you with their own words.

Published
23 May 2019
From
POZ

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.